ProUroCare Medical Inc.
PUMD · OTC
12/31/2012 | 12/31/2011 | 12/31/2010 | 12/31/2009 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $1 | $0 | $0 | $2 |
| G&A Expenses | $1 | $0 | $2 | $2 |
| SG&A Expenses | $1 | $1 | $2 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $2 | $2 | $2 | $4 |
| Operating Income | -$2 | -$2 | -$2 | -$4 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$1 | -$1 | $2 | -$3 |
| Pre-Tax Income | -$3 | -$2 | $0 | $0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$3 | -$2 | -$6 | -$7 |
| % Margin | – | – | – | – |
| EPS | -0.17 | -0.13 | -0.44 | -0.73 |
| % Growth | -30.8% | 70.5% | 39.7% | – |
| EPS Diluted | -0.17 | -0.13 | -0.44 | -0.73 |
| Weighted Avg Shares Out | 17 | 16 | 14 | 10 |
| Weighted Avg Shares Out Dil | 17 | 16 | 14 | 10 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $1 | $1 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$3 | -$2 | -$2 | -$4 |
| % Margin | – | – | – | – |